Skip to main content

Table 2 Study population demographics and clinical measures at baseline

From: Virtual reality-based vision therapy versus OBVAT in the treatment of convergence insufficiency, accommodative dysfunction: a pilot randomized controlled trial

 

Virtual reality-based vision therapy,

mean ± SD

Office-based vergence/accommodative therapy, mean ± SD

P value

Convergence insufficiency

 Sex, M: F

5:11

6:11

1.000

 Age (year)

23.63 ± 1.75

23.53 ± 2.00

0.885

 Right eye spherical equivalent, (D)

-3.91 ± 1.97

-3.60 ± 2.29

0.680

 Left eye spherical equivalent, (D)

-3.67 ± 1.94

-2.88 ± 2.41

0.310

 Phoria at distance (cover test) (△)

-3.75 ± 3.62

-2.88 ± 2.76

0.443

 Phoria at near (cover test) (△)

-16.31 ± 3.99

-15.35 ± 2.83

0.430

 NPC break (cm)

6.60 ± 3.63

6.00 ± 2.95

0.763

 Gradient AC/A ratio

2.44 ± 2.21

2.68 ± 2.29

0.979

 Calculated AC/A ratio

1.59 ± 1.40

1.61 ± 1.16

0.609

 PFV break at near, (△)

22.53 ± 6.15

23.06 ± 5.18

0.828

 PFV recovery at near, (△)

9.03 ± 8.85

9.88 ± 7.31

0.765

 CISS score

27.69 ± 8.46

25.18 ± 9.40

0.427

Accommodative dysfunction

 Sex, M: F

7:8

5:10

0.710

 Age (year)

23.07 ± 1.87

23.13 ± 2.03

0.926

 Right eye spherical equivalent, (D)

-4.37 ± 1.90

-3.90 ± 2.06

0.525

 Left eye spherical equivalent, (D)

-4.03 ± 1.83

-3.43 ± 2.40

0.447

 NRA, (D)

2.38 ± 0.40

2.47 ± 0.25

0.583

 PRA, (D)

-2.90 ± 1.75

-2.59 ± 0.65

0.644

 BCC, (D)

0.06 ± 1.06

0.34 ± 1.02

0.596

 Monocular accommodative amplitude, (D)

10.94 ± 3.76

10.41 ± 2.66

0.750

 Monocular accommodative facility, (cpm)

6.31 ± 2.56

4.94 ± 4.44

0.461

  1. NPC near point of convergence, AC/A accommodative convergence to accommodation, PFV positive fusional vergence, CISS Convergence Insufficiency Symptoms Survey, NRA negative relative accommodation, PRA positive relative accommodative, BCC binocular cross-cyclinder, D diopters, â–³ prism diopters, cpm cycles per minute